ASHLAND INC (ASH)
(Delayed Data from NYSE)
$96.28 USD
+1.34 (1.41%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $96.27 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth B Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$96.28 USD
+1.34 (1.41%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $96.27 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
B Value C Growth B Momentum B VGM
Zacks News
Ashland (ASH) Benefits From Strong End-Market Demand & Pricing
by Zacks Equity Research
Ashland (ASH) gains on solid demand in most consumer end markets and its pricing and mix improvement actions to counter cost inflation.
Ashland (ASH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Ashland (ASH) closed at $97.25 in the latest trading session, marking a +1.89% move from the prior day.
Here's Why You Should Add Ashland (ASH) Stock to Your Portfolio
by Zacks Equity Research
Ashland (ASH) gains on strong demand and its pricing and mix improvement actions to counter inflation.
Ashland (ASH) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Ashland (ASH) closed at $110.51 in the latest trading session, marking a +0.29% move from the prior day.
Ashland (ASH) Launches Gafchromic LD-V1 Film, Boosts Portfolio
by Zacks Equity Research
Ashland's (ASH) latest addition, Gafchromic LD-V1 film includes improved contrast and imaging detail.
Ashland (ASH) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
Ashland (ASH) closed at $105.29 in the latest trading session, marking a -1.62% move from the prior day.
Ashland (ASH) Down 4.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Ashland (ASH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Ashland (ASH) Hikes Dividend by 12%, Declares $500M Buyback
by Zacks Equity Research
Ashland (ASH) announces a quarterly cash dividend of 33.5 cents per share on its common stock.
Ashland (ASH) Just Overtook the 20-Day Moving Average
by Zacks Equity Research
Should investors be excited or worried when a stock crosses above the 20-day simple moving average?
Ashland's (ASH) Earnings and Revenues Surpass Estimates in Q2
by Zacks Equity Research
Ashland (ASH) benefits from strong demand across its end markets, disciplined pricing and better product mix in Q2.
Ashland (ASH) Beats Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Ashland (ASH) delivered earnings and revenue surprises of 10.29% and 0.02%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Olin (OLN) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Olin's (OLN) Q1 performance is likely to have benefited from productivity actions and the Lake City U.S. Army ammunition contract.
The Zacks Analyst Blog Highlights PotlatchDeltic, Range Resources, Matador Resources, Ashland Global Holdings and Helmerich & Payne
by Zacks Equity Research
PotlatchDeltic, Range Resources, Matador Resources, Ashland Global Holdings and Helmerich & Payne have been included in this Analyst Blog.
Buy 5 Mid-Cap Stocks Ahead of Earnings Results Next Week
by Nalak Das
Five mid-cap companies will report earnings results next week. These are: PCH, RRC, MTDR, ASH, HP.
Sherwin-Williams (SHW) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Sherwin-Williams (SHW) Q1 performance is likely to have benefited from strong demand as well as pricing and cost-control initiatives.
After Golden Cross, Ashland (ASH)'s Technical Outlook is Bright
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
Should You Buy Ashland (ASH) Ahead of Earnings?
by Zacks Equity Research
Ashland (ASH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Daqo New Energy (DQ) Beats Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Daqo (DQ) delivered earnings and revenue surprises of 11.13% and 11.62%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ashland (ASH) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does Ashland (ASH) have what it takes to be a top stock pick for momentum investors? Let's find out.
Ashland (ASH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Ashland (ASH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PPG Industries (PPG) to Post Q1 Earnings: What's in the Offing?
by Zacks Equity Research
PPG Industries' (PPG) Q1 performance is likely to have benefited from cost actions and acquisitions. Raw material inflation and supply-chain issues are expected to have hurt results.
Ashland (ASH) Updates Q2 Earnings and Affirms FY22 Outlook
by Zacks Equity Research
Ashland (ASH) anticipates net income to be around $786 million for Q2 driven by strong end-market demand, enhanced pricing and improved product mix.
Ashland (ASH) to Hike Price upto 15% to Cover Higher Costs
by Zacks Equity Research
Ashland's (ASH) price hike includes all Ashland products across all the markets and applications the company serves.
Ashland (ASH) Launches Nutrapress Organic Chewable Base
by Zacks Equity Research
Ashland (ASH) creates the organic chewable base with patent-pending technology.
Ashland (ASH) Wraps Up Sale of Performance Adhesives Unit
by Zacks Equity Research
Ashland (ASH) completes sale of the Performance Adhesives business to Arkema for $1.65 billion.